期刊文献+

威海地区8家医院多重耐药菌分布特征 被引量:3

Distribution characteristics of multidrug-resistant bacteria in 8 hospitals in Weihai District
下载PDF
导出
摘要 目的了解山东省威海地区多重耐药菌(MDR)的临床分布及流行状况,为预防控制MDR感染的暴发流行提供参考依据。方法收集2017年10月1日-2018年9月30日威海地区8家教学医院(3家三级甲等综合性医院、3家三级甲等专科医院、2家二级甲等医院)送检的各类标本,按照统一方案进行细菌培养鉴定及耐药性检测,采用纸片扩散法(K-B法)、自动化仪器法进行药敏试验,按照美国临床实验室标准化协会(CLSI)2017年版标准判读结果,用Whonet 5.6软件统计分析分离菌的临床分布特点。结果威海地区8家医院1年内共检出10 218株细菌,MDR为2 077株,检出率20.33%,其中大肠埃希菌(Eco)、鲍曼不动杆菌(Aba)、肺炎克雷伯菌(Kpn)、铜绿假单胞菌(Pae)、金黄色葡萄球菌MDR总检出率分别为51.18%、10.83%、18.92%、7.08%、11.99%。分离出的MDR主要包括产超广谱β-内酰胺酶大肠杆菌(ESBLs-Eco)、产超广谱β-内酰胺酶肺炎克雷伯菌(ESBLs-Kpn)、耐甲氧西林金黄色葡萄球菌(MRSA)、耐碳青霉烯类鲍曼不动杆菌(CR-Aba)、耐碳青霉烯类铜绿假单胞菌(CR-Pae),分别占各类病原菌的44.10%(1 076/2 440)、25.64%(391/1 525)、17.47%(253/1 448)、52.28%(218/417)、13.94%(149/1 069)。MDR多分布在ICU(16.47%)、神经外科(7.51%)、泌尿外科(6.45%)、神经内科(3.80%)、呼吸内科(3.37%)等。在痰液标本的检出率最高(28.36%),其次为尿液标本(24.69%)和分泌物标本(16.99%)。结论威海地区MDR感染状况严峻,临床应加强MDR的监测与管理,减少MDR菌株的产生,避免其在院内播散。 Objective To understand the clinical distribution and epidemic status of multidrug-resistant bacteria and provide reference evidences for the prevention and control of the epidemic outbreak of multidrugresistant bacteria(MDR) infection. Methods From October 1, 2017 to September 30, 2018, all kinds of specimens were collected from 8 teaching hospitals(3 Grade three A comprehensive hospitals, 3 Grade three A specialized hospitals, 2 Grade two A hospitals) in Weihai district. According to a unified plan, the identification of the bacterial cultures and detection of drugs resistance were carried out, the disc diffusion method(K-B method) and automation instrument method were used to perform drug sensitive tests, based on the standards in American Clinical Laboratory Standardization Institute(CLSI) of 2017 edition, the results were interpreted, and Whonet 5.6 statistical software was used to analyze the clinical distribution characteristics of isolated bacteria. Results A total of 10 218 strains of bacteria were detected in 8 hospitals in Weihai district within one year, and 2 077 strains of MDR were detected, the detection rate being 20.33%. Of them, the total MDR detection rates of Escherichia coli, Acinetobacter bowman, Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus were 51.18%, 10.83%,18.92%, 7.08% and 11.99%, respectively. The isolated MDR mainly included Escherichia coli producing extended beta-lactamase(ESBLs-Eco), Klebsiella pneumonia producing extended beta-lactamase(ESBLs-kpn), methicillinresistant Staphylococcus aureus(MRSA), carbapenem-resistant Acinetobacter bowman(CR-Aba) and carbapenemresistant Pseudomonas aeruginosa(CR-Pea), accounting for 44.10%(1 076/2 440), 25.64%(391/1 525), 17.47%(253/1 448), 52.28%(218/417) and 13.94%(149/1 069) of its own total strains of pathogenic bacteria, respectively.MDR were mainly distributed in ICU(16.47%), Neurosurgery(7.51%), Urology(6.45%), Neurology(3.80%),Respiratory Medicine(3.37%) Departments, etc. The highest detection rate was found in sputum(28.36%), followed by urine(24.69%) and secretions(16.99%) specimens. Conclusions The infection situation of multi-drug resistant bacteria in Weihai District is severe. The monitoring and management of multi-drug resistant bacteria should be strengthened in clinics to reduce the generation of multi-drug resistant strains and avoid their spread in hospitals.
作者 李进红 邵淑丽 王可玲 毕艳妮 袁颖 马淑青 王颖 Li Jinhong;Shao Shuli;Wang Keling;Bi Yanni;Yuan Ying;Ma Shuqing;Wang Ying(Department of Laboratory,Affiliated Weihai Second Municipal Hospital of Qingdao University, Weihai 264200, Shandong, China;Central Laboratory, Weihai Municipal Hospital, Weihai 264200, Shandong, China;Department of Endocrinology, Weihai Municipal Hospital, Weihai 264200, Shandong, China)
出处 《实用检验医师杂志》 2019年第2期75-78,共4页 Chinese Journal of Clinical Pathologist
基金 山东省保健科技协会科学技术课题(SDBJKT20180035)~~
关键词 多重耐药菌 威海地区 临床分布 检测 Multidrug-resistant bacteria Weihai District Clinical distribution Monitoring
  • 相关文献

参考文献6

二级参考文献58

  • 1杨平满,周建英.常见多重耐药菌的耐药机制及防治对策[J].中华医院感染学杂志,2006,16(12):1434-1437. 被引量:145
  • 2章瑞云,钱小毛.铜绿假单胞菌在重症监护病房流行及控制措施[J].中华医院感染学杂志,2007,17(3):269-271. 被引量:31
  • 3徐丽英,朱美珍,刘彩霞,吴爱红.多重耐药鲍曼不动杆菌医院感染的暴发和控制[J].浙江中西医结合杂志,2007,17(5):325-326. 被引量:14
  • 4孙迎娟,董国英,丁钰,李慧,刘蓬蓬.医院感染病原菌的分布及耐药性分析[J].中华医院感染学杂志,2007,17(9):1141-1144. 被引量:61
  • 5Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey [ J ]. Clin Infect Dis, 2005, 40 (4) :562-573.
  • 6Clinical and Laboratory Standards Institute.Performancestandards for antimicrobial susceptibility testing;twentieth informational supplement[S].CLSI,2010,30(1):M100-S20.
  • 7Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 8Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 9Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 10Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.

共引文献741

同被引文献44

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部